Considerations for Child Cancer Survivors and Immunocompromised Children to Prevent Secondary HPV-associated Cancers
PublisherWolters Kluwer Health
MetadataShow full item record
AbstractSurvivors of childhood cancer and other immunocompromised children are at high risk for the development of secondary human papillomavirus (HPV)-associated cancers. In this overview, the authors examine the epidemiology of vaccine efficacy, the natural history of HPV infections, and accelerated HPV-associated cancer development in these populations. The authors highlight the opportunities for preventive care and future research directives.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15145
- Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.
- Authors: Klosky JL, Favaro B, Peck KR, Simmons JL, Russell KM, Green DM, Hudson MM
- Issue date: 2016 Jun
- HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors.
- Authors: Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka D
- Issue date: 2019
- Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.
- Authors: Klosky JL, Russell KM, Canavera KE, Gammel HL, Hodges JR, Foster RH, Parra GR, Simmons JL, Green DM, Hudson MM
- Issue date: 2013 Oct
- Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
- Authors: Temkin SM, Seibel NL
- Issue date: 2015 Oct 1
- Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.
- Authors: York JM, Klosky JL, Chen Y, Connelly JA, Wasilewski-Masker K, Giuliano AR, Robison LL, Wong FL, Hudson MM, Bhatia S, Landier W
- Issue date: 2020 Sep 1